Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avian Flu Plan From Administration Places Vaccines First, Antivirals Second

Executive Summary

The Bush Administration's pandemic flu preparedness plans call for a dramatic expansion in the stockpiling of antivirals, an increase expected to be largely paid for by the states
Advertisement

Related Content

FDA Budget Targets CBER For Pandemic Funds, Creates Flu Strain Library
FDA Budget Targets CBER For Pandemic Funds, Creates Flu Strain Library
Liability Protections For Pandemic Vaccine Makers Provided In Spending Law
Liability Protections For Pandemic Vaccine Makers Provided In Spending Law
Tamiflu Population Differences Could Be Studied In U.K, HMO Databases
Tamiflu Population Differences Could Be Studied In U.K, HMO Databases
Howdy Partners: Von Eschenbach Pledges More Collaborations With NIH
Howdy Partners: Von Eschenbach Pledges More Collaborations With NIH
Pfizer CEO Proposes Specialized Medical Courts; Not Worried About Bextra
Unused Flu Vaccine Would Be Purchased By HHS Under Draft “BioShield II”

Topics

Advertisement
UsernamePublicRestriction

Register

PS046508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel